Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
ATTO Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/atto/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Attovia Therapeutics, Inc. (ATTO) Insider Trading

11 open-market trades reported since Aug 6, 2026: 9 purchases worth $52.4M and 2 sales worth $4.50M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Goldman Sachs Group IncOther2$10.3M1$2.25MAug 13, 2026
Colin WalshDirector2$10.3M1$2.25MAug 13, 2026
Venbio Global Strategic Fund Iv, L.P.10% owner1$6.50M0$0Aug 10, 2026
Redmile Group, LLC10% owner2$10.2M0$0Aug 7, 2026
Sanofi10% owner1$5.10M0$0Aug 7, 2026
Frazier Life Sciences Xi, L.P.10% owner1$10.00M0$0Aug 6, 2026

All trades

ATTO insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHolding3 mo. afterFiling
Aug 13Aug 6Goldman Sachs Group IncOtherOther (ind.)▲ BUY500,00017.00$8.50M49+20%Form 4 ↗
Aug 13Aug 6Colin WalshDirectorDirector (ind.)▲ BUY500,00017.00$8.50M52+20%Form 4 ↗
Aug 13Aug 5Goldman Sachs Group IncOtherOther (ind.)▼ SELL105,80721.28$2.25M−58%Form 4 ↗
Aug 13Aug 5Colin WalshDirectorDirector (ind.)▼ SELL105,80721.28$2.25M−58%Form 4 ↗
Aug 13Aug 5Goldman Sachs Group IncOtherOther (ind.)▲ BUY85,00021.00$1.78M56NewForm 4 ↗
Aug 13Aug 5Colin WalshDirectorDirector (ind.)▲ BUY85,00021.00$1.78M59NewForm 4 ↗
Aug 10Aug 6Venbio Global Strategic Fund Iv, L.P.10% owner10% owner▲ BUY382,35217.00$6.50M48+10%Form 4 ↗
Aug 7Aug 6Redmile Group, LLC10% owner10% owner (ind.)▲ BUY400,00017.00$6.80M58+51%Form 4 ↗
Aug 7Aug 6Sanofi10% owner10% owner (ind.)▲ BUY300,00017.00$5.10M53+38%Form 4 ↗
Aug 7Aug 6Redmile Group, LLC10% owner10% owner▲ BUY200,00017.00$3.40M50+26%Form 4 ↗
Aug 6Aug 6Frazier Life Sciences Xi, L.P.10% owner10% owner▲ BUY588,23517.00$10.00M48+11%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings